» Articles » PMID: 31056474

Stemness Underpinning All Steps of Human Colorectal Cancer Defines the Core of Effective Therapeutic Strategies

Abstract

Background: Despite their lethality and ensuing clinical and therapeutic relevance, circulating tumor cells (CTCs) from colorectal carcinoma (CRC) remain elusive, poorly characterized biological entities.

Methods And Findings: We perfected a cell system of stable, primary lines from human CRC showing that they possess the full complement of ex- and in-vivo, in xenogeneic models, characteristics of CRC stem cells (CCSCs). Here we show how tumor-initiating, CCSCs cells can establish faithful orthotopic phenocopies of the original disease, which contain cells that spread into the circulatory system. While in the vascular bed, these cells retain stemness, thus qualifying as circulating CCSCs (cCCSCs). This is followed by the establishment of lesions in distant organs, which also contain resident metastatic CCSCs (mCCSCs).

Interpretation: Our results support the concept that throughout all the stages of CRC, stemness is retained as a continuous property by some of their tumor cells. Importantly, we describe a useful standardized model that can enable isolation and stable perpetuation of human CRC's CCSCs, cCCSCs and mCCSCs, providing a useful platform for studies of CRC initiation and progression that is suitable for the discovery of reliable stage-specific biomarkers and the refinement of new patient-tailored therapies. FUND: This work was financially supported by grants from "Ministero della Salute Italiano"(GR-2011-02351534, RC1703IC36 and RC1803IC35) to Elena Binda and from "Associazione Italiana Cancro" (IG-14368) Angelo L. Vescovi. None of the above funders have any role in study design, data collection, data analysis, interpretation, writing the project.

Citing Articles

BRAF mutations and the association of V600E with CD133 and CDX2 expression in a Pakistani colorectal carcinoma cohort.

Hassan S, Mirza T, Khatoon A, Bukhari U, Shaikh F, Karim A BMC Cancer. 2024; 24(1):1162.

PMID: 39300378 PMC: 11411998. DOI: 10.1186/s12885-024-12925-z.


Different states of stemness of glioblastoma stem cells sustain glioblastoma subtypes indicating novel clinical biomarkers and high-efficacy customized therapies.

Visioli A, Trivieri N, Mencarelli G, Giani F, Copetti M, Palumbo O J Exp Clin Cancer Res. 2023; 42(1):244.

PMID: 37735434 PMC: 10512479. DOI: 10.1186/s13046-023-02811-0.


1'-O-methyl-averantin isolated from the endolichenic fungus Jackrogersella sp. EL001672 suppresses colorectal cancer stemness via sonic Hedgehog and Notch signaling.

Varli M, Lee E, Yang Y, Zhou R, Tas I, Pulat S Sci Rep. 2023; 13(1):2811.

PMID: 36797277 PMC: 9935543. DOI: 10.1038/s41598-023-28773-z.


Patient-derived xenograft model in colorectal cancer basic and translational research.

Liu X, Xin Z, Wang K Animal Model Exp Med. 2022; 6(1):26-40.

PMID: 36543756 PMC: 9986239. DOI: 10.1002/ame2.12299.


Growth factor independence underpins a paroxysmal, aggressive Wnt5a/EphA2 phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy.

Trivieri N, Visioli A, Mencarelli G, Cariglia M, Marongiu L, Pracella R J Exp Clin Cancer Res. 2022; 41(1):139.

PMID: 35414102 PMC: 9004109. DOI: 10.1186/s13046-022-02333-1.


References
1.
Zeuner A, Todaro M, Stassi G, De Maria R . Colorectal cancer stem cells: from the crypt to the clinic. Cell Stem Cell. 2014; 15(6):692-705. DOI: 10.1016/j.stem.2014.11.012. View

2.
Binda E, Visioli A, Giani F, Trivieri N, Palumbo O, Restelli S . Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells. Cancer Res. 2016; 77(4):996-1007. DOI: 10.1158/0008-5472.CAN-16-1693. View

3.
Binda E, Visioli A, Giani F, Lamorte G, Copetti M, Pitter K . The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas. Cancer Cell. 2012; 22(6):765-80. PMC: 3922047. DOI: 10.1016/j.ccr.2012.11.005. View

4.
Vermeulen L, de Sousa E Melo F, van der Heijden M, Cameron K, de Jong J, Borovski T . Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol. 2010; 12(5):468-76. DOI: 10.1038/ncb2048. View

5.
van der Flier L, Clevers H . Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol. 2008; 71:241-60. DOI: 10.1146/annurev.physiol.010908.163145. View